跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LAURAK 250 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LAURAK 250 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG
Approved
STANDARD
LAURAK 250 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG
Neuraxpharm Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 15, 2024
Approval ID
07086c8b8875231a
Company
Neuraxpharm Spain S.L.
Type
Standard
Approval Details
Approval Id
07086c8b8875231a
Drug Cima Aemps Name
LAURAK 250 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG
Register Number
89241
Holder Company Name
Neuraxpharm Spain S.L.
Marketing Company Name
Neuraxpharm Spain S.L.
Authorization Date
2024-01-15
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
250 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Neuraxpharm Spain S.L.
Active Ingredients
LEVETIRACETAM
250 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 15, 2024
Approval ID
07086c8b8875231a
Type
Standard
Back to CIMA-AEMPS Approvals